Explore how ARID1A mutations drive gastric cancer through epigenetic reprogramming and discover promising therapeutic strategies targeting these vulnerabilities.
Explore how hypermethylation silences tumor suppressor genes in gastric cardia adenocarcinoma, its clinical implications, and future therapeutic approaches.